Rev-erbα heterozygosity produces a dose-dependent phenotypic advantage in mice. 由 Ryan D Welch, Cyrielle Billon, Amina Kameric, Thomas P Burris, Colin A Flaveny

獲取全文

The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis 由 Kristine Griffett, Ryan D. Welch, Colin A. Flaveny, Grant R. Kolar, Brent A. Neuschwander-Tetri, Thomas P. Burris

獲取全文

A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis. 由 Monideepa Sengupta, Suomia Abuirqeba, Amina Kameric, Aurore Cecile-Valfort, Arindam Chatterjee, Kristine Griffett, Thomas P Burris, Colin A Flaveny

獲取全文

Repurposing the FDA-approved pinworm drug pyrvinium as a novel chemotherapeutic agent for intestinal polyposis. 由 Bin Li, Colin A Flaveny, Camilla Giambelli, Dennis Liang Fei, Lu Han, Brian I Hang, Feng Bai, Xin-Hai Pei, Vania Nose, Oname Burlingame, Anthony J Capobianco, Darren Orton, Ethan Lee, David J Robbins

獲取全文